210345-04-3

210345-04-3 structure

Name: Z-LEHD-FMK
Chemical Name: Z-Leu-Glu(OMe)-His-Asp(OMe) fluoromethyl ketone
CAS Number: 210345-04-3
Molecular Formula: C₃₂H₄₃FN₆O₁₀
Molecular Weight: 690.71600
Catalog: Signaling Pathways Apoptosis Caspase
Create Date: 2017-11-19 04:29:14
Modify Date: 2024-01-12 12:23:52
Z-LEHD-FMK is a selective and irreversible inhibitor of caspase-9, protects against lethal reperfusion injury and attenuates apoptosis. Z-LEHD-FMK exhibits the neuroprotective effect in a rat model of spinal cord trauma[1][2][3].

Name	Z-Leu-Glu(OMe)-His-Asp(OMe) fluoromethyl ketone
Synonyms	Z-LE(OMe)HD(OMe)-FMK Z-LEHD-FMK

Description	Z-LEHD-FMK is a selective and irreversible inhibitor of caspase-9, protects against lethal reperfusion injury and attenuates apoptosis. Z-LEHD-FMK exhibits the neuroprotective effect in a rat model of spinal cord trauma[1][2][3].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Apoptosis >> Caspase Research Areas >> Neurological Disease
Target	Caspase-9
In Vitro	Z-LEHD-FMK (20 μM; pretreated for 30 min) completely protects HCT116 and 293 cells from TRAIL-induced toxicity[1]. Z-LEHD-FMK (20 μM ; 6 h) protects normal human hepatocytes from TRAIL-induced apoptosis[1]. Apoptosis Analysis[1] Cell Line: SW480, H460, HCT116 and 293 cells Concentration: 20 μM Incubation Time: Pretreated for 30 min Result: Protected HCT116 and 293 cells from TRAIL-induced apoptosis. Western Blot Analysis[1] Cell Line: HCT116, SW480 cells Concentration: 20 μM Incubation Time: 2 h Result: Protected procaspase 3 from cleavage in HCT116 cells but not in SW480 cells, especially at the 16-h time point.
In Vivo	Z-LEHD-FMK (0.8 μmol/kg; i.v. for 7 d) protects neurons, glia, myelin, axons, and intracellular organelles in spinal cord injury (SCI) rats[2]. Animal Model: Male Wistar albino rats (250-350 g) with SCI[2] Dosage: 0.8 μmol/kg Administration: I.v. for 1 or 7 days Result: Decreased the mean apoptotic cell count at 24 hours and 7 days postinjury.
References	[1]. Ozoren N, et, al. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 2000 Nov 15; 60(22): 6259-65. [2]. Colak A, et, al. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine. 2005 Mar; 2(3): 327-34. [3]. Mocanu MM, et, al. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol. 2000 May; 130(2): 197-200.

Molecular Formula	C₃₂H₄₃FN₆O₁₀
Molecular Weight	690.71600
Exact Mass	690.30200
PSA	223.98000
LogP	2.36620

210345-04-3	524746-03-0
1381885-28-4	133410-84-1
96922-64-4	210344-92-6
105608-85-3	210345-00-9
210344-96-0	1135688-47-9
1090559-78-6	1158522-08-7
940364-43-2	134104-43-1
131615-57-1	6906-52-1
930439-75-1	1018584-77-4
1375289-11-4	849349-65-1